BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of 21.52 billion. The enterprise value is 20.02 billion.
| Market Cap | 21.52B |
| Enterprise Value | 20.02B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 57.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -38.22 |
| EV / Sales | 6.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.57 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.98 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.85 |
| Interest Coverage | -242.90 |
Financial Efficiency
Return on equity (ROE) is -14.62% and return on invested capital (ROIC) is -12.41%.
| Return on Equity (ROE) | -14.62% |
| Return on Assets (ROA) | -9.69% |
| Return on Capital (ROIC) | -12.41% |
| Revenue Per Employee | 309,654 |
| Profits Per Employee | -52,370 |
| Employee Count | 10,600 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.62 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 722 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, BeiGene had revenue of 3.10 billion and -523.70 million in losses. Loss per share was -5.01.
| Revenue | 3.10B |
| Gross Profit | 2.63B |
| Operating Income | -887.08M |
| Pretax Income | -470.78M |
| Net Income | -523.70M |
| EBITDA | -795.99M |
| EBIT | -887.08M |
| Loss Per Share | -5.01 |
Balance Sheet
The company has 2.59 billion in cash and 1.09 billion in debt, giving a net cash position of 1.50 billion.
| Cash & Cash Equivalents | 2.59B |
| Total Debt | 1.09B |
| Net Cash | 1.50B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.37B |
| Book Value Per Share | 31.73 |
| Working Capital | 1.90B |
Cash Flow
In the last 12 months, operating cash flow was -703.95 million and capital expenditures -581.37 million, giving a free cash flow of -1.29 billion.
| Operating Cash Flow | -703.95M |
| Capital Expenditures | -581.37M |
| Free Cash Flow | -1.29B |
| FCF Per Share | n/a |
Margins
Gross margin is 84.98%, with operating and profit margins of -28.65% and -16.91%.
| Gross Margin | 84.98% |
| Operating Margin | -28.65% |
| Pretax Margin | -15.20% |
| Profit Margin | -16.91% |
| EBITDA Margin | -25.71% |
| EBIT Margin | -28.65% |
| FCF Margin | -41.51% |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -32.35% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 3.04.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | n/a |